Work

Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report

Year: 2013

Type: article

Abstract: Papillary tumor of the pineal region (PTPR) is a rare brain tumor that probably arises from ependymal cells. There are no known systemic treatments for PTPR once it is refractory to surgery and radiation. We present the first case of a durable radiographic and clinical response of a PTPR to bevacizumab, an antibody against vascular endothelial growth factor, despite multiple prior treatments. Bevacizumab may be an effective treatment for PTPR.

Source: Case Reports in Oncology

DOI: 10.1159/000354753

Authors: Adam L. Cohen, Karen Salzman, Cheryl Palmer, Randy Jensen, Howard Colman

Institutions: Huntsman Cancer Institute, University of Utah

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,170